Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Intellia Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 283
- −10 vs. Q1 2025
- Shares held
- 99.5M
- −1.74M (−1.7%) vs. Q1 2025
- Total value
- $933.8M
- +$213.6M (+29.7%) vs. Q1 2025
- New holders
- 42
- 111 more added
- Sold out
- 52
- 88 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −25,520−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −23,967−100.0% | Sold out |
| Prosperity Wealth Management, Inc. | 0 | $0 | 0.00% | −23,700−100.0% | Sold out |
| Polymer Capital Management (US) LLC | 0 | $0 | 0.00% | −15,230−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −13,789−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −13,406−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −12,751−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −11,683−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −11,473−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −11,258−100.0% | Sold out |
| 49 Wealth Management, LLC | 0 | $0 | 0.00% | −10,427−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −10,085−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −8,953−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −5,859−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −7,892−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −6,663−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −5,065−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −2,520−100.0% | Sold out |
| Roxbury Financial LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Stonebridge Financial Group, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Western Pacific Wealth Management, LP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| IAG Wealth Partners, LLC | 0 | $0 | 0.00% | −480−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −439−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −404−100.0% | Sold out |
| Promus Capital, LLC | 0 | $0 | 0.00% | −401−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Beacon Capital Management, LLC | 0 | $0 | 0.00% | −164−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Goodman Advisory Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| First Pacific Financial | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| CAPROCK Group, Inc. | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |
| Sandy Spring Bank | – | – | – | – | Not filed |